al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
VIVUS to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Business Editors/Health/Medical Writers
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--May 19, 2008--VIVUS, Inc. (NASDAQ:
VVUS) a pharmaceutical company dedicated to the development and
commercialization of novel therapeutic products, today announced that Dr.
Barbara Troupin, clinical development director, will present an overview of the
company at the Rodman & Renshaw 5 th Annual Global Healthcare conference in
Monte Carlo, Monaco.
The VIVUS presentation will take place at the Le Meridien Beach Plaza Hotel on
Tuesday, May 20, 2008 at 3:20 p.m. CET. A live audio webcast and 14-day archive
of the presentation will be available at http://ir.vivus.com.
About VIVUS
VIVUS, Inc. is a pharmaceutical company dedicated to the development and
commercialization of novel therapeutic products. The current portfolio includes
investigational products addressing obesity and sexual health. The pipeline
includes: Qnexa", which is in phase 3 for the treatment of obesity and phase 2
for the treatment of type 2 diabetes; Testosterone MDTS®, for which a phase 2
study has been completed for the treatment of Hypoactive Sexual Desire Disorder
(HSDD); and avanafil, for which a phase 2 study has been completed for the
treatment of erectile dysfunction (ED). For more information on clinical trials
and products, please visit the company's web site at http://www.vivus.com.
VIVUS, Inc.
Timothy E. Morris, 650-934-5200
Chief Finanمن ضمن ابحاثها تبي تنتج فياغرا نسائيه cial Officer
7.30 h
Business Editors/Health/Medical Writers
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--May 19, 2008--VIVUS, Inc. (NASDAQ:
VVUS) a pharmaceutical company dedicated to the development and
commercialization of novel therapeutic products, today announced that Dr.
Barbara Troupin, clinical development director, will present an overview of the
company at the Rodman & Renshaw 5 th Annual Global Healthcare conference in
Monte Carlo, Monaco.
The VIVUS presentation will take place at the Le Meridien Beach Plaza Hotel on
Tuesday, May 20, 2008 at 3:20 p.m. CET. A live audio webcast and 14-day archive
of the presentation will be available at http://ir.vivus.com.
About VIVUS
VIVUS, Inc. is a pharmaceutical company dedicated to the development and
commercialization of novel therapeutic products. The current portfolio includes
investigational products addressing obesity and sexual health. The pipeline
includes: Qnexa", which is in phase 3 for the treatment of obesity and phase 2
for the treatment of type 2 diabetes; Testosterone MDTS®, for which a phase 2
study has been completed for the treatment of Hypoactive Sexual Desire Disorder
(HSDD); and avanafil, for which a phase 2 study has been completed for the
treatment of erectile dysfunction (ED). For more information on clinical trials
and products, please visit the company's web site at http://www.vivus.com.
VIVUS, Inc.
Timothy E. Morris, 650-934-5200
Chief Finanمن ضمن ابحاثها تبي تنتج فياغرا نسائيه cial Officer
7.30 h
